See also this year's filing and all EDGAR filings for this company.
PDF Report 0001842952_2022_Context_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001842952', 'EntityCommonStockSharesOutstanding': 15966053, 'Assets': 37965943, 'AssetsCurrent': 37853658, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 3207577, 'LiabilitiesAndStockholdersEquity': 37965943, 'LiabilitiesCurrent': 3207577, 'LiabilitiesNoncurrent': 0, 'NetIncome': -14835939, 'PropertyPlantAndEquipmentNet': 27568, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 84717, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 34758366, 'remainder_NetIncome': -14835939, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001842952, Context Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,255,361 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 50,389 |
| 4 | LiabilitiesCurrent | 3,033,415 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 64,240 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -10,392,630 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 51,305,750 |
| 1 | Liabilities | 3,033,415 |
| 2 | Expenses | 64,240 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 48,272,335 |
| 5 | NetIncome | -10,456,870 |
| 6 | ComprehensiveNetIncome | -10,456,870 |
| 7 | BaseVar | 32,398,018 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.49 |
| 9 | EconomicCapitalRatio | 4.02 |